Sodium hyaluronate eye drops containing 0.01% of atropine and preparation method of sodium hyaluronate eye drops

A technology of sodium hyaluronate and atropine, which can be used in medical formulations containing active ingredients, pharmaceutical formulations, and medical formulations with non-active ingredients, etc., and can solve problems such as no drug interaction.

Pending Publication Date: 2020-10-23
SECOND AFFILIATED HOSPITAL OF COLLEGE OF MEDICINEOF XIAN JIAOTONG UNIV
View PDF4 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

In addition, sodium hyaluronate eye drops have no systemic effects other than basic local physical effects (sur

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0042] formula:

[0043] sodium hyaluronate 1 g Atropine sulfate 0.1 g hydrochloric acid Appropriate amount Sodium chloride 9 g Water for Injection 1000 ml

[0044] The preparation method of the sodium hyaluronate eye drops that the present embodiment contains 0.01% atropine adopts the following steps:

[0045] (1) Weigh 1 g of sodium hyaluronate, add 500 ml of water for injection to dissolve, and obtain sodium hyaluronate solution after swelling overnight;

[0046] (2) Weigh 9 g of sodium chloride, add it into 200 ml of water for injection to dissolve, and obtain the osmotic pressure regulator solution after completely dissolving;

[0047] (3) Mix the solution obtained in step (1) and step (2), and add water for injection to make the total volume reach 1000ml, then stir evenly;

[0048] (4) Take an appropriate amount of hydrochloric acid and add it to the solution obtained in step (3) to adjust the pH value to 4.5-6;

[0049] (5) In a...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses sodium hyaluronate eye drops containing 0.01% of atropine. The eye drops comprise sodium hyaluronate, atropine, sodium hydroxide, hydrogen chloride, sodium chloride and water for injection. The mass concentration of sodium hyaluronate is 0.1-10 g/L, the mass concentration of atropine is 0.1 g/L, sodium hydroxide and hydrogen chloride are pH regulators, and sodium chloride is an osmotic pressure regulator. The eye drops contain no traditional Chinese medicinal components, bacteriostatic agent, preservative, cosolvent, thicken agent, complexing agent or the like, the components are simple and are normal substances of human bodies except for atropine, so that corneal damage caused by damage of the microenvironment on the surfaces of eyeballs is avoid, harm to the humanbodies and growth and development due to long-term excessive use of components such as traditional Chinese medicine is also avoided, and the incidence of allergic reaction is effectively reduced. Inaddition, the eye drops have pH and osmotic pressure adjusted, use comfort is improved, small-dose independent packages are also produced based on aseptic filling and a hot pressing sterilization process, and biological safety of the product is ensured.

Description

technical field [0001] The invention belongs to the technical field of pharmaceutical preparations, and in particular relates to a sodium hyaluronate eye drop containing 0.01% atropine and a preparation method thereof. Background technique [0002] Myopia is a kind of refractive error, which refers to a kind of eye disease that reduces vision, sees distant objects blurred, and sees near objects clearly. After wearing glasses for correction, distance vision can be improved. With the changes in people's lifestyle, eating habits and living environment, the number of myopia patients is increasing year by year, and the age of onset tends to be younger, especially in school-age children. At present, my country has become a big country with myopia, and the number of people suffering from myopia ranks first in the world, and the high incidence of myopia among young people and the younger age have become public health problems that have attracted much attention. In 2016, Peking Univ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K9/08A61K47/02A61K47/04A61K31/46A61K31/728A61P27/10
CPCA61K9/08A61K9/0048A61K47/02A61K31/46A61K31/728A61P27/10A61K2300/00
Inventor 任鹏宇张虹党晓洁韩鹏王睿闫春妮
Owner SECOND AFFILIATED HOSPITAL OF COLLEGE OF MEDICINEOF XIAN JIAOTONG UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products